Legend Biotech director Peter Salovey reports acquisition of $183,250 in common shares
LEGN•Director Peter Salovey purchased 20,000 Legend Biotech ordinary shares for a total of $183,250, raising his direct beneficial ownership to 75,096 shares.
LEGN•Director Peter Salovey purchased 20,000 Legend Biotech ordinary shares for a total of $183,250, raising his direct beneficial ownership to 75,096 shares.
Salovey purchased 10,000 shares at $9.375 each and 10,000 shares at $8.95 each. His direct beneficial ownership rose to 75,096 ordinary shares.